Sp1 Contributes to Radioresistance of Cervical Cancer Through Targeting G2/M Cell Cycle Checkpoint CDK1 [Corrigendum]
Deng YR, Chen XJ, Chen W, et al. Cancer Manag Res. 2019;11:5835–5844. The authors have advised due to an error at the time of figure assembly, Figure 3A on page 5840 is incorrect. The correct Figure 3 is shown in Download Article. The authors apologize for this error and advise it does not...
Enregistré dans:
Auteurs principaux: | Deng YR, Chen XJ, Chen W, Wu LF, Jiang HP, Lin D, Wang LJ, Wang W, Guo SQ |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/c0f1c0c4c98e4eb5b9a5fc4ca1ac1ae2 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
The Role of CDK4 in the Pathogenesis of Pancreatic Cancer
par: Emily Jiggens, et autres
Publié: (2021) -
REV1 Inhibition Enhances Radioresistance and Autophagy
par: Kanayo E. Ikeh, et autres
Publié: (2021) -
Involvement of Non-Coding RNAs in Chemo- and Radioresistance of Nasopharyngeal Carcinoma
par: Xiao J, et autres
Publié: (2021) -
Non-Coding RNAs Associated With Radioresistance in Triple-Negative Breast Cancer
par: Alberto Aranza-Martínez, et autres
Publié: (2021) -
Characterization of Recurrent Relevant Genes Reveals a Novel Role of RPL36A in Radioresistant Oral Squamous Cell Carcinoma
par: Ting-Wen Chen, et autres
Publié: (2021)